Nontuberculous mycobacteria in lung transplant recipients: Prevalence, risk factors and impact on survival and chronic lung allograft dysfunction.

07:00 EST 3rd December 2019 | BioPortfolio

Summary of "Nontuberculous mycobacteria in lung transplant recipients: Prevalence, risk factors and impact on survival and chronic lung allograft dysfunction."

Nontuberculous mycobacteria (NTM) are environmental organisms that colonize or infect lung transplant recipients. Due to differences in populations studied and geographical diversity of species, risk factors for infection and its impact on patient outcomes post-transplant are conflicting in the literature.


Journal Details

This article was published in the following journal.

Name: Transplant infectious disease : an official journal of the Transplantation Society
ISSN: 1399-3062
Pages: e13229


DeepDyve research library

PubMed Articles [27404 Associated PubMed Articles listed on BioPortfolio]

Multidrug-resistant Acinetobacter baumannii infection in lung transplant recipients: risk factors and prognosis.

Infectious complication is an important cause of poor outcome of lung transplantation (LT). Infections with Acinetobacter baumannii (A. baumannii) are problematic, because of limited therapeutic optio...

Discharge frailty following lung transplantation.

Frailty at listing for lung transplant has been associated with waitlist and post-transplant mortality. Frailty trajectories following transplant, however, have been less well characterized, including...

Hepatitis E seroprevalence and associated risk factors in Croatian liver transplant recipients.

Solid-organ transplant recipients are at risk of hepatitis E virus (HEV) infection. We analyzed the seroprevalence/risk factors of HEV in Croatian liver transplant recipients.

Prevalence of Frailty among Kidney Transplant Candidates and Recipients in the United States: Estimates from a National Registry and Multi-center Cohort Study.

Frailty, a measure of physiologic reserve, is associated with poor outcomes and mortality among kidney transplant (KT) candidates and recipients. There are no national estimates of frailty in this pop...

Nontuberculous Mycobacteria, Botswana, 2011-2014.

We documented a 6-fold increase in the frequency of nontuberculous mycobacteria isolated from clinical samples in Botswana during 2011-2014. Because antituberculosis treatment is often initiated only ...

Clinical Trials [18950 Associated Clinical Trials listed on BioPortfolio]

Clarithromycin for the Treatment of Infections Caused by Nontuberculous Mycobacteria (NTM)

Use of oral clarithromycin for treatment of chronic lung disease due to Mycobacterium avium-intracellulare and other non-tuberculous Mycobacteria

Recombinant Interleukin-7 (CYT107) to Treat Patients With Refractory Nontuberculous Mycobacterial Lung Disease

A prospective, single-center, open-label study involving patients with refractory nontuberculous mycobacteria lung disease to ascertain pharmacokinetics, safety, efficacy, and tolerability...

Prospective Evaluations of Infectious Complication in Lung Transplant Recipients

The primary aim of this study is to determine prospectively the viral and C. pneumoniae infection prevalence and outcomes of infections in lung transplant recipients. The study will also ...

A Registry for Nontuberculous Mycobacterial Pulmonary Disease

Background: NTM(Nontuberculous mycobacteria) pulmonary disease is increasing worldwidely, however the diagnosis and treatment of NTM pulmonary disease still has multiple obstacles. The in...

Safety and Efficacy of Ingenol Mebutate Gel 0.015% for Treatment of AK on the Face in Solid Organ Transplant Recipients

This is a single arm, open-label interventional study of ingenol mebutate 0.015% in solid organ transplant recipients. The investigators plan to treat 20 subjects, 10 kidney transplant rec...

Medical and Biotech [MESH] Definitions

Infections with nontuberculous mycobacteria (atypical mycobacteria): M. kansasii, M. marinum, M. scrofulaceum, M. flavescens, M. gordonae, M. obuense, M. gilvum, M. duvali, M. szulgai, M. intracellulare (see MYCOBACTERIUM AVIUM COMPLEX;), M. xenopi (littorale), M. ulcerans, M. buruli, M. terrae, M. fortuitum (minetti, giae), M. chelonae.

Pulmonary or extrapulmonary infection caused by MYCOBACTERIUM TUBERCULOSIS or nontuberculous mycobacteria in a patient with silicosis.

Non-cadaveric providers of organs for transplant to related or non-related recipients.

Individuals receiving tissues or organs transferred from another individual of the same or different species, or from within the same individual.

The procedure established to evaluate the health status and risk factors of the potential DONORS of biological materials. Donors are selected based on the principles that their health will not be compromised in the process, and the donated materials, such as TISSUES or organs, are safe for reuse in the recipients.

Quick Search

DeepDyve research library

Relevant Topics

Pulmonary relating to or associated with the lungs eg Asthma, chronic bronchitis, emphysema, COPD, Cystic Fibrosis, Influenza,  Lung Cancer, Pneumonia, Pulmonary Arterial Hypertension, Sleep Disorders etc Follow and track Lung Cancer News ...

Antiretroviral Therapy Clostridium Difficile Ebola HIV & AIDS Infectious Diseases Influenza Malaria Measles Sepsis Swine Flu Tropical Medicine Tuberculosis Infectious diseases are caused by pathogenic...

Searches Linking to this Article